AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand · Delayed Price · Currency is NZD 3.980
+0.050 (1.27%)
Jun 2, 2026, 11:03 AM NZST
AFT Pharmaceuticals Company Description
AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
The company offers proprietary and in-licensed products, including patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, natural health, pain management, skin care, sleeping aids, supplements, and other products.
It has a research and development collaboration with Hyloris Pharmaceuticals SA for the development of the Maxigesic IV product.
AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
AFT Pharmaceuticals Limited
| Country | New Zealand |
| Founded | 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 119 |
| CEO | Hartley Atkinson |
Contact Details
Address: 129 Hurstmere Road Auckland, 0622 New Zealand | |
| Phone | 64 8 0042 3823 |
| Website | aftpharm.com |
Stock Details
| Ticker Symbol | AFT |
| Exchange | New Zealand Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | NZD |
| ISIN Number | NZAFTE0001S4 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hartley Atkinson | Chief Executive Officer |
| Simon Bosley | Chief Financial Officer |